They further observed elevated levels of CD33+ MDSC levels at recurrence correlated with overall survival, whereas infiltration of MDSCs into the tumor microenvironment correlated with poor prognosis (Figure 1(b)) [35]. The gene discussed is CD33; the disease is neoplasm.